1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)
  4. Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/220012
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSelvitella, Silvia-
dc.contributor.authorFranco, Marta Pérez-
dc.contributor.authorAran, Begoña-
dc.contributor.authorVeiga, Anna-
dc.contributor.authorKuebler, Bernd-
dc.date.accessioned2025-03-25T15:07:36Z-
dc.date.available2025-03-25T15:07:36Z-
dc.date.issued2024-12-01-
dc.identifier.issn1876-7753-
dc.identifier.urihttps://hdl.handle.net/2445/220012-
dc.description.abstractmRNA reprogramming is a technology for generating iPSCs with high efficiency and safety. However, it is not suitable for reprogramming non-adherent cells, the primary cell type in blood. An alternative is to obtain adherent cells from blood for this technology. To validate this approach, we generated a human iPSC line from blood outgrowth endothelial cells (BOECs) using mRNA-based reprogramming. The resulting line, CTRL EiPS J9 mR6F-8, meets iPSC criteria, including an undifferentiated state, pluripotency, genome integrity. This line is available upon request.-
dc.format.extent5 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier BV-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.scr.2024.103606-
dc.relation.ispartofStem Cell Research, 2024, vol. 81-
dc.relation.urihttps://doi.org/10.1016/j.scr.2024.103606-
dc.rightscc-by (c) Selvitella, Silvia et al., 2024-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationEnginyeria genètica-
dc.subject.classificationEndoteli-
dc.subject.classificationCèl·lules-
dc.subject.otherGenetic engineering-
dc.subject.otherEndothelium-
dc.subject.otherCells-
dc.titleGeneration of the CTRL EiPS J9 mR6F-8 iPSC line derived from healthy human outgrowth blood endothelial cells (BOECs) using mRNA reprogramming methodology-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2024-12-10T10:35:35Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid39541769-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
1-s2.0-S1873506124003040-main.pdf5.48 MBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons